tiprankstipranks
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market
WHWK
Whitehawk Therapeutics
RESEARCH TOOLSreports

Whitehawk Therapeutics (WHWK) Income Statement

498 Followers

Whitehawk Therapeutics Income Statement

Last quarter (Q4 2025), Whitehawk Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Whitehawk Therapeutics's net income was $-23.25M. See Whitehawk Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.14M$ 25.98M$ 24.35M$ 15.22M$ 1.12M
Gross Profit
$ 6.38M$ -28.07M$ -27.38M$ -18.78M$ -18.55M
Operating Expenses
$ 120.78M$ 39.39M$ 44.55M$ 43.90M$ 92.67M
Depreciation and Amortization
$ 0.00$ 193.00K$ 169.00K$ 159.00K$ 105.00K
EBITDA
$ -114.40M$ -64.63M$ -71.76M$ -58.80M$ -36.96M
Operating Income
$ -114.40M$ -67.46M$ -71.93M$ -62.68M$ -111.22M
Other Income/Expenses
$ 93.80M$ 3.77M$ 6.17M$ 2.17M$ 1.13M
Pretax Income
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Net Income
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Per Share Metrics
Basic EPS
$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Diluted EPS
$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Weighted Average Shares Outstanding
 61.89M 27.03M 26.92M 22.51M 8.87M
Weighted Average Shares Outstanding (Diluted)
 61.89M 27.03M 26.92M 22.51M 8.92M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History